Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).

Lee PY, Kellner ES, Huang Y, Furutani E, Huang Z, Bainter W, Alosaimi MF, Stafstrom K, Platt CD, Stauber T, Raz S, Tirosh I, Weiss A, Jordan MB, Krupski C, Eleftheriou D, Brogan P, Sobh A, Baz Z, Lefranc G, Irani C, Kilic SS, El-Owaidy R, Lokeshwar MR, Pimpale P, Khubchandani R, Chambers EP, Chou J, Geha RS, Nigrovic PA, Zhou Q.

J Allergy Clin Immunol. 2020 Jan 13. pii: S0091-6749(20)30030-0. doi: 10.1016/j.jaci.2019.12.908. [Epub ahead of print]

PMID:
31945408
2.

Genetic and phenotypic spectrum associated with IFIH1 gain-of-function.

Rice GI, Park S, Gavazzi F, Adang LA, Ayuk LA, Van Eyck L, Seabra L, Barrea C, Battini R, Belot A, Berg S, Billette de Villemeur T, Bley AE, Blumkin L, Boespflug-Tanguy O, Briggs TA, Brimble E, Dale RC, Darin N, Debray FG, De Giorgis V, Denecke J, Doummar D, Drake Af Hagelsrum G, Eleftheriou D, Estienne M, Fazzi E, Feillet F, Galli J, Hartog N, Harvengt J, Heron B, Heron D, Kelly DA, Lev D, Levrat V, Livingston JH, Marti I, Mignot C, Mochel F, Nougues MC, Oppermann I, Pérez-Dueñas B, Popp B, Rodero MP, Rodriguez D, Saletti V, Sharpe C, Tonduti D, Vadlamani G, Van Haren K, Tomas Vila M, Vogt J, Wassmer E, Wiedemann A, Wilson CJ, Zerem A, Zweier C, Zuberi SM, Orcesi S, Vanderver AL, Hur S, Crow YJ.

Hum Mutat. 2020 Jan 3. doi: 10.1002/humu.23975. [Epub ahead of print]

PMID:
31898846
3.

Microparticle-mediated VZV propagation and endothelial activation: Mechanism of VZV vasculopathy.

Eleftheriou D, Moraitis E, Hong Y, Turmaine M, Venturini C, Ganesan V, Breuer J, Klein N, Brogan P.

Neurology. 2019 Dec 31. pii: 10.1212/WNL.0000000000008885. doi: 10.1212/WNL.0000000000008885. [Epub ahead of print]

PMID:
31892634
4.

TRAP1 chaperone protein mutations and autoinflammation.

Standing AS, Hong Y, Paisan-Ruiz C, Omoyinmi E, Medlar A, Stanescu H, Kleta R, Rowcenzio D, Hawkins P, Lachmann H, McDermott MF, Eleftheriou D, Klein N, Brogan PA.

Life Sci Alliance. 2019 Dec 27;3(2). pii: e201900376. doi: 10.26508/lsa.201900376. Print 2020 Feb.

5.

Lifetime cardiovascular management of patients with previous Kawasaki disease.

Brogan P, Burns JC, Cornish J, Diwakar V, Eleftheriou D, Gordon JB, Gray HH, Johnson TW, Levin M, Malik I, MacCarthy P, McCormack R, Miller O, Tulloh RMR.

Heart. 2019 Dec 16. pii: heartjnl-2019-315925. doi: 10.1136/heartjnl-2019-315925. [Epub ahead of print] Review.

6.

Secondary C1q Deficiency in Activated PI3Kδ Syndrome Type 2.

Hong Y, Nanthapisal S, Omoyinmi E, Olbrich P, Neth O, Speckmann C, Lucena JM, Gilmour K, Worth A; Genomics England Research Consortium, Klein N, Eleftheriou D, Brogan P.

Front Immunol. 2019 Nov 11;10:2589. doi: 10.3389/fimmu.2019.02589. eCollection 2019.

7.

Janus kinase inhibition for autoinflammation in patients with DNASE2 deficiency.

Hong Y, Capitani M, Murphy C, Pandey S, Cavounidis A, Takeshita H, Nanthapisal S, Yasuda T, Bader-Meunier B, McCreary D, Omoyinmi E, Rao A, Booth C, Gilmour K, Sebire N, Shah N, Klein N, Bullock AN, Eleftheriou D, Uhlig HH, Brogan P.

J Allergy Clin Immunol. 2019 Nov 24. pii: S0091-6749(19)31602-1. doi: 10.1016/j.jaci.2019.11.020. [Epub ahead of print] No abstract available.

8.

Development and Validation of a Targeted Next-Generation Sequencing Gene Panel for Children With Neuroinflammation.

McCreary D, Omoyinmi E, Hong Y, Mulhern C, Papadopoulou C, Casimir M, Hacohen Y, Nyanhete R, Ahlfors H, Cullup T, Lim M, Gilmour K, Mankad K, Wassmer E, Berg S, Hemingway C, Brogan P, Eleftheriou D.

JAMA Netw Open. 2019 Oct 2;2(10):e1914274. doi: 10.1001/jamanetworkopen.2019.14274.

9.

Centromedian thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES - Two different outcomes.

Sa M, Singh R, Pujar S, D'Arco F, Desai N, Eltze C, Hughes E, Al Obaidi M, Eleftheriou D, Tisdall M, Selway R, Cross JH, Kaliakatsos M, Valentin A.

Eur J Paediatr Neurol. 2019 Sep;23(5):749-754. doi: 10.1016/j.ejpn.2019.08.001. Epub 2019 Aug 8.

PMID:
31446001
10.

Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review.

Garg S, Wynne K, Omoyinmi E, Eleftheriou D, Brogan P.

Rheumatol Adv Pract. 2019 Feb 12;3(1):rkz004. doi: 10.1093/rap/rkz004. eCollection 2019.

11.

Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome.

Elmi AA, Wynne K, Cheng IL, Eleftheriou D, Lachmann HJ, Hawkins PN, Brogan P.

Pediatr Rheumatol Online J. 2019 Jul 8;17(1):36. doi: 10.1186/s12969-019-0335-4.

12.

Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus.

Moraitis E, Stathopoulos Y, Hong Y, Al-Obaidi M, Mankad K, Hacohen Y, Sen D, Hemingway C, Eleftheriou D.

Lupus. 2019 Sep;28(10):1243-1249. doi: 10.1177/0961203319855125. Epub 2019 Jun 18.

PMID:
31213132
13.

Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation.

Mulhern CM, Hong Y, Omoyinmi E, Jacques TS, D'Arco F, Hemingway C, Brogan PA, Eleftheriou D.

J Allergy Clin Immunol. 2019 Sep;144(3):863-866.e5. doi: 10.1016/j.jaci.2019.05.026. Epub 2019 Jun 5. No abstract available.

14.

Development of a benchmarking toolkit for adolescent and young adult rheumatology services (BeTAR).

Cai RA, Chaplin H, Livermore P, Lee M, Sen D, Wedderburn LR, Wilkinson N, Jeffery R, Kempa A, Norton I, Tattersall R, Ioannou Y, Eleftheriou D.

Pediatr Rheumatol Online J. 2019 May 21;17(1):23. doi: 10.1186/s12969-019-0323-8.

15.

Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune diseases.

Pan S, Yu H, Surti A, Cheng I, Marks SD, Brogan PA, Eleftheriou D, Standing JF.

Br J Clin Pharmacol. 2019 Aug;85(8):1790-1797. doi: 10.1111/bcp.13970. Epub 2019 Jun 20.

16.

Monogenic mimics of Behçet's disease in the young.

Papadopoulou C, Omoyinmi E, Standing A, Pain CE, Booth C, D'Arco F, Gilmour K, Buckland M, Eleftheriou D, Brogan PA.

Rheumatology (Oxford). 2019 Jul 1;58(7):1227-1238. doi: 10.1093/rheumatology/key445.

PMID:
30715505
17.

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.

Papadopoulou C, Hong Y, Omoyinmi E, Brogan PA, Eleftheriou D.

Brain. 2019 Mar 1;142(3):e8. doi: 10.1093/brain/awz005. No abstract available.

18.

Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management.

Lythgoe H, Almeida B, Bennett J, Bhat C, Bilkhu A, Brennan M, Deepak S, Dawson P, Eleftheriou D, Harrison K, Hawley D, Heaf E, Leone V, Long E, Maltby S, McErlane F, Rafiq N, Ramanan AV, Riley P, Rangaraj S, Varnier G, Wilkinson N, Pain CE.

Pediatr Rheumatol Online J. 2018 Dec 18;16(1):80. doi: 10.1186/s12969-018-0295-0.

19.

European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative.

de Graeff N, Groot N, Ozen S, Eleftheriou D, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen-Kerkhof A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Brogan P, Beresford MW.

Rheumatology (Oxford). 2019 Apr 1;58(4):672-682. doi: 10.1093/rheumatology/key344.

PMID:
30535127
20.

Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in C3.

Omoyinmi E, Mohamoud I, Gilmour K, Brogan PA, Eleftheriou D.

Front Immunol. 2018 Nov 1;9:2524. doi: 10.3389/fimmu.2018.02524. eCollection 2018.

21.

Mediterranean diet and its components in relation to all-cause mortality: meta-analysis.

Eleftheriou D, Benetou V, Trichopoulou A, La Vecchia C, Bamia C.

Br J Nutr. 2018 Nov;120(10):1081-1097. doi: 10.1017/S0007114518002593.

22.

Autoinflammation due to homozygous S208 MEFV mutation.

Hong Y, Standing ASI, Nanthapisal S, Sebire N, Jolles S, Omoyinmi E, Verstegen RH, Brogan PA, Eleftheriou D.

Ann Rheum Dis. 2019 Apr;78(4):571-573. doi: 10.1136/annrheumdis-2018-214102. Epub 2018 Oct 24. No abstract available.

23.

Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ.

Lei L, Muhammad S, Al-Obaidi M, Sebire N, Cheng IL, Eleftheriou D, Brogan P.

Pediatr Rheumatol Online J. 2018 Sep 26;16(1):61. doi: 10.1186/s12969-018-0278-1.

24.

Genetic interferonopathies: An overview.

Eleftheriou D, Brogan PA.

Best Pract Res Clin Rheumatol. 2017 Aug;31(4):441-459. doi: 10.1016/j.berh.2017.12.002. Epub 2018 Feb 1. Review.

PMID:
29773266
25.

Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.

Nanthapisal S, Eleftheriou D, Gilmour K, Leone V, Ramnath R, Omoyinmi E, Hong Y, Klein N, Brogan PA.

Front Immunol. 2018 Apr 11;9:735. doi: 10.3389/fimmu.2018.00735. eCollection 2018.

26.

Moyamoya-like cerebrovascular disease in a child with a novel mutation in myosin heavy chain 11.

Keylock A, Hong Y, Saunders D, Omoyinmi E, Mulhern C, Roebuck D, Brogan P, Ganesan V, Eleftheriou D.

Neurology. 2018 Jan 16;90(3):136-138. doi: 10.1212/WNL.0000000000004828. Epub 2017 Dec 20. No abstract available.

27.

Determination of annual and seasonal daytime and nighttime trends of MODIS LST over Greece - climate change implications.

Eleftheriou D, Kiachidis K, Kalmintzis G, Kalea A, Bantasis C, Koumadoraki P, Spathara ME, Tsolaki A, Tzampazidou MI, Gemitzi A.

Sci Total Environ. 2018 Mar;616-617:937-947. doi: 10.1016/j.scitotenv.2017.10.226. Epub 2017 Nov 6.

PMID:
29107377
28.

Developing and Evaluating JIApp: Acceptability and Usability of a Smartphone App System to Improve Self-Management in Young People With Juvenile Idiopathic Arthritis.

Cai RA, Beste D, Chaplin H, Varakliotis S, Suffield L, Josephs F, Sen D, Wedderburn LR, Ioannou Y, Hailes S, Eleftheriou D.

JMIR Mhealth Uhealth. 2017 Aug 15;5(8):e121. doi: 10.2196/mhealth.7229.

29.

Vasculitis update: pathogenesis and biomarkers.

Brogan P, Eleftheriou D.

Pediatr Nephrol. 2018 Feb;33(2):187-198. doi: 10.1007/s00467-017-3597-4. Epub 2017 Aug 7. Review.

30.

Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis.

Omoyinmi E, Standing A, Keylock A, Price-Kuehne F, Melo Gomes S, Rowczenio D, Nanthapisal S, Cullup T, Nyanhete R, Ashton E, Murphy C, Clarke M, Ahlfors H, Jenkins L, Gilmour K, Eleftheriou D, Lachmann HJ, Hawkins PN, Klein N, Brogan PA.

PLoS One. 2017 Jul 27;12(7):e0181874. doi: 10.1371/journal.pone.0181874. eCollection 2017.

31.

Microparticles in acute coronary syndrome.

Mavroudis CA, Eleftheriou D, Hong Y, Majumder B, Koganti S, Sapsford R, North J, Lowdell M, Klein N, Brogan P, Rakhit RD.

Thromb Res. 2017 Aug;156:109-116. doi: 10.1016/j.thromres.2017.06.003. Epub 2017 Jun 9.

PMID:
28624718
32.

Necrotic cutaneous vasculitic skin lesions: a case of atypical Henoch-Schönlein purpura in a child with heterozygosity for factor V Leiden.

Dhanjal S, Saso A, Eleftheriou D, Laurent S.

BMJ Case Rep. 2017 May 22;2017. pii: bcr2016218903. doi: 10.1136/bcr-2016-218903. No abstract available.

33.

Decreased antibodies against hepatitis A in previously vaccinated treatment naïve juvenile SLE patients: a prospective case control study.

Maritsi DN, Eleftheriou D, Onoufriou M, Vartzelis G.

Clin Exp Rheumatol. 2017 May-Jun;35(3):544-545. Epub 2017 Mar 8. No abstract available.

PMID:
28281464
34.

Microparticles and their role in coronary artery disease.

Koganti S, Eleftheriou D, Brogan PA, Kotecha T, Hong Y, Rakhit RD.

Int J Cardiol. 2017 Mar 1;230:339-345. doi: 10.1016/j.ijcard.2016.12.108. Epub 2016 Dec 22. Review.

PMID:
28040277
35.

Early-Onset Juvenile SLE Associated With a Novel Mutation in Protein Kinase C δ.

Nanthapisal S, Omoyinmi E, Murphy C, Standing A, Eisenhut M, Eleftheriou D, Brogan PA.

Pediatrics. 2017 Jan;139(1). pii: e20160781. doi: 10.1542/peds.2016-0781. Epub 2016 Dec 21.

36.

Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1.

Standing AS, Malinova D, Hong Y, Record J, Moulding D, Blundell MP, Nowak K, Jones H, Omoyinmi E, Gilmour KC, Medlar A, Stanescu H, Kleta R, Anderson G, Nanthapisal S, Gomes SM, Klein N, Eleftheriou D, Thrasher AJ, Brogan PA.

J Exp Med. 2017 Jan;214(1):59-71. doi: 10.1084/jem.20161228. Epub 2016 Dec 19.

37.

A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet's Syndrome.

Khan E, Ambrose NL, Ahnström J, Kiprianos AP, Stanford MR, Eleftheriou D, Brogan PA, Mason JC, Johns M, Laffan MA, Haskard DO.

Sci Rep. 2016 Dec 7;6:38104. doi: 10.1038/srep38104.

38.

Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus.

Al-Obaidi M, Saunders D, Brown S, Ramsden L, Martin N, Moraitis E, Pilkington CA, Brogan PA, Eleftheriou D.

Clin Rheumatol. 2016 Oct;35(10):2449-56. doi: 10.1007/s10067-016-3376-9. Epub 2016 Aug 15.

39.

Granulomatosis with polyangiitis mimicking infective endocarditis in an adolescent male.

Varnier GC, Sebire N, Christov G, Eleftheriou D, Brogan PA.

Clin Rheumatol. 2016 Sep;35(9):2369-72. doi: 10.1007/s10067-016-3337-3. Epub 2016 Jul 1.

PMID:
27370964
40.

Complete clinical remission with tocilizumab in two infants with systemic juvenile idiopathic arthritis: a case series.

Maritsi DN, Onoufriou M, Vartzelis G, Eleftheriou D.

Scand J Rheumatol. 2017 Jan;46(1):75-76. doi: 10.3109/03009742.2016.1164243. Epub 2016 May 24. No abstract available.

PMID:
27218706
41.

Progressive neurologic disorder: Initial manifestation of hemophagocytic lymphohistiocytosis.

Murphy C, Nanthapisal S, Gilmour K, Laurent S, D'Arco F, Hemingway C, Brogan P, Eleftheriou D.

Neurology. 2016 May 31;86(22):2109-11. doi: 10.1212/WNL.0000000000002729. Epub 2016 Apr 29. No abstract available.

42.

Therapeutic advances in the treatment of vasculitis.

Eleftheriou D, Brogan PA.

Pediatr Rheumatol Online J. 2016 Apr 26;14(1):26. doi: 10.1186/s12969-016-0082-8. Review.

43.

The lived experience of juvenile idiopathic arthritis in young people receiving etanercept.

Livermore P, Eleftheriou D, Wedderburn LR.

Pediatr Rheumatol Online J. 2016 Apr 12;14(1):21. doi: 10.1186/s12969-016-0083-7.

44.

Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.

Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, Ekelund M, Jolles S, Harper L, Youngstein T, Gilmour K, Klein NJ, Eleftheriou D, Brogan PA.

Arthritis Rheumatol. 2016 Sep;68(9):2314-22. doi: 10.1002/art.39699.

45.

Eosinophilic granulomatosis with polyangiitis in childhood: retrospective experience from a tertiary referral centre in the UK.

Eleftheriou D, Gale H, Pilkington C, Fenton M, Sebire NJ, Brogan PA.

Rheumatology (Oxford). 2016 Jul;55(7):1263-72. doi: 10.1093/rheumatology/kew029. Epub 2016 Mar 29.

PMID:
27026726
46.

Mitochondrial and oxidative stress genes are differentially expressed in neutrophils of sJIA patients treated with tocilizumab: a pilot microarray study.

Omoyinmi E, Hamaoui R, Bryant A, Jiang MC, Athigapanich T, Eleftheriou D, Hubank M, Brogan P, Woo P.

Pediatr Rheumatol Online J. 2016 Feb 9;14(1):7. doi: 10.1186/s12969-016-0067-7.

47.

Radiologic Improvement After Early Medical Intervention in Localised Facial Morphea.

Khan MA, Shaw L, Eleftheriou D, Prabhakar P, Chong WK, Glover M.

Pediatr Dermatol. 2016 Mar-Apr;33(2):e95-8. doi: 10.1111/pde.12799. Epub 2016 Feb 10.

PMID:
26860318
48.

Paediatric Behçet's disease: a UK tertiary centre experience.

Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA.

Clin Rheumatol. 2016 Oct;35(10):2509-16. doi: 10.1007/s10067-016-3187-z. Epub 2016 Feb 1.

49.

Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis.

Wu Q, Chaplin H, Ambrose N, Sen D, Leandro MJ, Wing C, Daly N, Webb K, Fisher C, Suffield L, Josephs F, Pilkington C, Eleftheriou D, Al-Obaidi M, Compeyrot-Lacassagne S, Wedderburn LR, Ioannou Y.

Ann Rheum Dis. 2016 Mar;75(3):635-6. doi: 10.1136/annrheumdis-2015-208462. Epub 2015 Dec 29. No abstract available.

50.

Screening assays for primary haemophagocytic lymphohistiocytosis in children presenting with suspected macrophage activation syndrome.

Cruikshank M, Anoop P, Nikolajeva O, Rao A, Rao K, Gilmour K, Eleftheriou D, Brogan PA.

Pediatr Rheumatol Online J. 2015 Nov 16;12 Suppl 1:48. doi: 10.1186/s12969-015-0043-7.

Supplemental Content

Loading ...
Support Center